首页> 外文期刊>Kidney International Reports >SAT-084 DIFFERENCE IN RATE OF DECLINE OF ISOAGGLUTININ TITERS BETWEEN SELECTIVE PLASMA EXCHANGE WITH AND WUTHOUT FRESH FROZEN PLASMA BEFORE ABO-INCOMPATIBLE KIDNEY TRANSPLANTATION
【24h】

SAT-084 DIFFERENCE IN RATE OF DECLINE OF ISOAGGLUTININ TITERS BETWEEN SELECTIVE PLASMA EXCHANGE WITH AND WUTHOUT FRESH FROZEN PLASMA BEFORE ABO-INCOMPATIBLE KIDNEY TRANSPLANTATION

机译:SAT-084肾不相容移植前选择性血浆交换与冻存新鲜血浆间异凝素滴度下降速率的差异

获取原文
       

摘要

Osaka City University Hospital, Medical Device, Osaka, Japan, 7Osaka City University Graduate School of Medicine, Urology, Osaka, Japan Introduction: Isoagglutinins removal by apheresis and immunosup- pressive therapy are generally performed at pre-transplant desensiti- zation of ABO-incompatible kidney transplantation. Selective plasma exchange (SePE) is a new simple plasma exchange (PE) modality that enables removal of small and medium-sized molecules without removing larger molecules, such as coagulation factors. Since 2015, we have always performed SePE using albumin solution in patients with a low isoagglutinin titers, or we added this approach in patients in whom the isoagglutinin titers was sufficiently decreased by double-filtration plasmapheresis (DFPP) and/or simple PE. However, although this pro- cedure is advantageous in that it has fewer adverse effects, it also removes about 30% of coagulation factors, such as fibrinogen and factor XIII, and this is problematic in the perioperative period. Thus, we currently perform SePE using fresh frozen plasma (FFP) as part of the replacement fluid in patients with a decline of coagulation factors. We have had a favorable impression clinically with regard to the decline of the antibody titer with use of FFP. In this study, we examined if this impression was supported by a significant difference in outcomes.
机译:大阪市立大学医院,医疗器械,日本大阪,7大阪市立大学医学研究生院,泌尿外科,日本大阪,简介:一般通过单采血液分离术和免疫抑制疗法去除异凝集素,方法是在移植前对不相容的ABO脱敏。肾脏移植。选择性血浆置换(SePE)是一种新的简单血浆置换(PE)方式,可去除中小分子而无需去除大分子,例如凝血因子。自2015年以来,我们一直在使用低凝凝素滴度的患者中使用白蛋白溶液进行SePE,或者在通过双重滤过血浆置换术(DFPP)和/或单纯PE充分降低凝凝素滴度的患者中添加了这种方法。但是,尽管该方法的优点是副作用少,但它也能去除大约30%的凝血因子,例如纤维蛋白原和XIII因子,这在围手术期存在问题。因此,我们目前在凝血因子下降的患者中使用新鲜冷冻血浆(FFP)作为替代液的一部分进行SePE。对于使用FFP的抗体效价下降,我们在临床上给人留下了良好的印象。在这项研究中,我们检查了这种印象是否得到结果显着差异的支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号